David Y.T. Chen - Concepedia

Author

David Y.T. Chen

Also Known As

D.Y.-T. Chen, David Y T Chen, David Y. T. Chen, David Y.-T. Chen, David Y.T Chen, David Y.T. Chen, David Yen-Ting Chen, David Yen‐Ting Chen, David Yen-Ting Chen, Karim Chamie

217

Publications

8.8K

Citations

H-Index

Concepts

All Affiliations

Fox Chase Cancer Center Temple University Health System Temple University Taipei Medical University-Shuang Ho Hospital Taipei Medical University

About

David Y.T. Chen is an author at Fox Chase Cancer Center specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	44	3.2K
2	Health Sciences	4	4	106
3	Public Health	3	3	100
4	Management	1	1	26
5	Natural Sciences	1	1	108

David Y.T. Chen

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Transcription Elongation by the VHL Tumor Suppressor Protein Delin Duan, Arnim Pause, Wilson H. Burgess, Science	1995	575
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer Elizabeth R. Plimack, Roland L. Dunbrack, Timothy Brennan, European Urology Genome InstabilityUrologyNeoadjuvant Cisplatin-based ChemotherapyGenitourinary CancerMedicine	2015	526
The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins Arnim Pause, Stephen Lee, Robert Worrell, Proceedings of the National Academy of Sciences	1997	499
Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity Elizabeth R. Plimack, Jean Hoffman‐Censits, Rosalia Viterbo, Journal of Clinical Oncology	2014	278
Objective Measures of Renal Mass Anatomic Complexity Predict Rates of Major Complications Following Partial Nephrectomy Jay Simhan, Marc C. Smaldone, Kevin Tsai, European Urology HemodialysisUrologyRenal DiseaseRenal FunctionRenal Care	2011	275
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019 Veda N. Giri, Karen E. Knudsen, William Kevin Kelly, Journal of Clinical Oncology	2020	273
Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score Alexander Kutikov, Marc C. Smaldone, Brian L. Egleston, European Urology Preoperative Nomogram UsingUrologyRenal FunctionGenitourinary CancerSurgical Pathology	2011	264
Enhancing Renal Masses With Zero Net Growth During Active Surveillance David A. Kunkle, Paul L. Crispen, David Y.T. Chen, The Journal of Urology	2007	213
Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance Paul L. Crispen, Rosalia Viterbo, Stephen A. Boorjian, Cancer	2009	197
Big GABA: Edited MR spectroscopy at 24 research sites Mark E. Mikkelsen, Peter B. Barker, Pallab Bhattacharyya, NeuroImage Magnetic Resonance SpectroscopySpectroscopyResonanceMagnetic ResonanceBig Gaba	2017	196

Page 1